REGENXBIO Inc. ($RGNX)
Filing Information
| Accession Number | 0001700659-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
129,783
Total Value
$977,414.32
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jun 29, 2026 | Sale | 19,608 | $11.04 | $216,472.32 | 213,009 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 1, 2026 | Exercise/Conversion | 36,725 | $7.86 | $288,658.50 | 249,734 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 1, 2026 | Sale | 36,725 | $12.86 | $472,283.50 | 213,009 | Direct | โ | View Details | |
Chief Medical Officer | Stock Options (Right to Buy) | Derivative | Jul 1, 2026 | Exercise/Conversion | 36,725 | $0.00 | $0.00 | 66,973 | Direct | โ | View Details |